Literature DB >> 25930103

Involvement of epimutations in meningioma.

Mario Venza1, Maria Visalli, Concetta Beninati, Teresa Catalano, Carmelo Biondo, Diana Teti, Isabella Venza.   

Abstract

Epimutations are heritable and reversible cell markers, which can influence cell function going beyond the effects of DNA mutations. They result from multiple and coordinated mechanisms able to modulate gene expression. Regarding the significance of epigenetics in meningioma, few and somehow contradictory results are available, although promising information has been obtained. Here we highlight the most recent advances about the impact of DNA methylation, histone modifications, and microRNA regulation on meningioma development as well as the interplay between genetic and epigenetic alterations. Data indicate that epigenetics can help to identify novel candidate genes for the management and treatment of meningioma.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25930103     DOI: 10.1007/s10014-015-0221-9

Source DB:  PubMed          Journal:  Brain Tumor Pathol        ISSN: 1433-7398            Impact factor:   3.298


  3 in total

1.  H3K27me3 loss indicates an increased risk of recurrence in the Tübingen meningioma cohort.

Authors:  Felix Behling; Christina Fodi; Irina Gepfner-Tuma; Kristina Kaltenbach; Mirjam Renovanz; Frank Paulsen; Marco Skardelly; Jürgen Honegger; Marcos Tatagiba; Jens Schittenhelm; Ghazaleh Tabatabai
Journal:  Neuro Oncol       Date:  2021-08-02       Impact factor: 12.300

Review 2.  The integrated multiomic diagnosis of sporadic meningiomas: a review of its clinical implications.

Authors:  Stephanie M Robert; Shaurey Vetsa; Arushii Nadar; Sagar Vasandani; Mark W Youngblood; Evan Gorelick; Lan Jin; Neelan Marianayagam; E Zeynep Erson-Omay; Murat Günel; Jennifer Moliterno
Journal:  J Neurooncol       Date:  2021-11-30       Impact factor: 4.130

3.  Differentially Expressed MicroRNAs in Meningiomas Grades I and II Suggest Shared Biomarkers with Malignant Tumors.

Authors:  Mohamed Raafat El-Gewely; Morten Andreassen; Mari Walquist; Anita Ursvik; Erik Knutsen; Mona Nystad; Dag H Coucheron; Kristin Smistad Myrmel; Rune Hennig; Steinar D Johansen
Journal:  Cancers (Basel)       Date:  2016-03-03       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.